Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2021 Financial Results and Conference CallBusiness Wire • 02/08/22
Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027Business Wire • 01/20/22
Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027Business Wire • 01/14/22
NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic DisordersBusiness Wire • 12/17/21
Hercules Capital Surpasses $2.0 Billion in Annual Gross Debt and Equity Commitments for First Time in HistoryBusiness Wire • 11/29/21
Hercules Capital Further Strengthens Its Capital Resources With New $100.0 Million Multi-Currency Credit FacilityBusiness Wire • 11/10/21
Hercules Capital, Inc. (HTGC) CEO Scott Bluestein on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/29/21
Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021Business Wire • 10/26/21
Hercules Capital Increases Its Quarterly Cash Distribution to $0.33 per Share for the Third Quarter of 2021Business Wire • 10/26/21
Earnings Preview: Hercules Technology (HTGC) Q3 Earnings Expected to DeclineZacks Investment Research • 10/21/21
Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of DirectorsBusiness Wire • 10/20/21
Locus Biosciences Secures Financing of up to $25 Million from Hercules CapitalGlobeNewsWire • 10/19/21
Hercules Capital Announces Date for Release of Third Quarter 2021 Financial Results and Conference CallBusiness Wire • 10/14/21